Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia
NCT05611086Phase 4Terminated
- Sponsor
- Teny Tjitra Sari
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in acute lymphoblastic leukemia (ALL) comparing NAC Group with Placebo (2 arms). Primary endpoints: Malondialdehyde at 7 weeks, Aspartate aminotransferase at 7 weeks and 2 more. Started Aug 2019; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT05611086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05611086.